Purchase, NY, May 5, 2009 – Nutrition 21, Inc. (Nasdaq: NXXI), a developer and marketer of nutritional supplements that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and address chronic joint pain, will report financial results - prior to the opening of the market - on Tuesday, May 12, 2009 for the third quarter of fiscal year 2009, ended March 31, 2009. The Company has scheduled a conference call to review the results later that morning, Tuesday, May 12, 2009 at 10:00AM ET.

Participants can dial (866) 562-9910 or (706) 679-5064 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.nutrition21.com. A replay of the call will be available by visiting http://www.nutrition21.com for 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 94814802, through May 15, 2009.

About Nutrition 21
Nutrition 21, Inc. (NASDAQ: NXXI), headquartered in Purchase, NY, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21’s portfolio of health and wellness products include: Iceland Health Chromax^', Iceland Health Life Advanced Memory Formula^™, Diabetes Essentials^™, Iceland Health^' Maximum Strength Omega-3 and Iceland Health^' Joint Relief. The company also manufactures private label supplements and ingredients for third parties. Nutrition 21 distributes its products nationally through more than 29,000 major food, drug and super center stores throughout the U.S. and internationally. For more information please visit http://www.nutrition21.com.